AON (AONC): Average Forecast Price

Symbol and logo of brand AON (AONC)

Current price action for American Oncology Network (AONC) reflects market expectations as the company implements RPA bots to digitize billing and card accounting, where the indicator stands at 0.00. The business relies on environmental sustainability by eliminating paper and ensuring safe waste disposal. The development model is based on creating a unified infrastructure for small centers, helping them compete effectively against industry behemoths.

AONC (American Oncology Network Inc) Analyst Consensus Forecast history from 02/21/2024 to 08/04/2024
Original product of American Oncology Network

Finding a balance between operational risks and return on capital at American Oncology Network (AONC) requires an analysis of the integration of AI diagnostics and the pharmacy hub into a single B2B circuit. This consensus target chart aggregates average investment bank estimates, reflecting the business's fundamental value through expected cash flows, which allows investors to separate market noise from the long-term sustainability of this medical ecosystem.

Competing companies

Analyst Consensus Forecast beigene.com (ONC)|Price Target Chart Halozyme HALO|Revolution Medicines Inc (RVMD) - Average Forecast Price|AAPG - Price Target Chart|CGON (CG Oncology Therapeutics) - Broker Consensus Forecast|URGN: Analyst Consensus Forecast|Consensus Target bicara.com|PSNL (Personalis) - Analyst Consensus Forecast|Consensus Target Erasca Inc (ERAS)|Analyst Consensus Forecast DCTH|Analyst Consensus Forecast Y-mAbs Corp (YMAB)|Price Target Chart Aura Biosciences, Inc. AURA|CADL: Broker Consensus Forecast|Accuray - Analyst Consensus Forecast|SELLAS Life Sciences (SLS) - Consensus Target|ACTU: Analyst Consensus Forecast|Average Forecast Price Citius Oncology Inc (CTOR)|Price Target Chart TuHURA Biosciences Inc.|TARA: Fair Value Consensus|Consensus Target FATE (Fate Therapeutics)|WHWK (aadibio.com) - Fair Value Consensus|Analyst Consensus Forecast TCRX (TScan Therapeutics, Inc.)|CSBR - Consensus Target|XBIT: Consensus Target|CVM - Analyst Consensus Forecast|OS Therapies (OSTX) - Price Target Chart|Radiopharm Theranostics Ltd - Fair Value Consensus|ARTV (Artiva Biotherapeutics Inc.) - Analyst Consensus Forecast|Average Forecast Price Adlai Nortye Limited ANL|Analyst Consensus Forecast VERU|Analyst Consensus Forecast tempesttx.com (TPST)|Price Target Chart Xilio Therapeutics XLO|RENB - Consensus Target|Mural Bio - Analyst Consensus Forecast|Average Forecast Price Kairos Pharma Ltd|onkuretherapeutics.com (OKUR) - Price Target Chart|CytoMed Therapeutics Limited - Fair Value Consensus|CRIS (Curis Inc.) - Analyst Consensus Forecast|Apollomics Corp (APLM) - Analyst Median Target|Analyst Consensus Forecast THAR|Consensus Target advanbiomed.com ADVB|Analyst Consensus Forecast GNPX (Genprex, Inc.)|Analyst Consensus Forecast Calidi Biotherapeutics Inc. CLDI|SBFM - Price Target Chart|XBIO (Xenetic Biosciences) - Broker Consensus Forecast|SLRX (Salarius) - Consensus Target|Kitov Pharma - Fair Value Consensus|Price Target Chart BeiGene, Ltd.|Average Forecast Price checkpointtx.com CKPT|Price Target Chart Elevation Oncology, Inc. (ELEV)|icadmed.com - Broker Consensus Forecast|Analyst Consensus Forecast IKNA (Ikena Oncology)|NTBL - Consensus Target|VIRX - Price Target Chart|Average Forecast Price morphosys.com|NAYA Biosciences Inc. (NAYA) - Price Target Chart|AAPGV (Ascentage Pharma Group International) - Price Target Chart